A Combination of an Antimitotic and a Bromodomain 4 Inhibitor Synergistically Inhibits the Metastatic MDA-MB-231 Breast Cancer Cell Line
Current chemotherapeutic agents have many side effects and are toxic to normal cells, providing impetus to identify agents that can effectively eliminate tumorigenic cells without damaging healthy cells. The aim of this study was to examine whether combining a novel BRD4 inhibitor, ITH-47, with the...
Main Authors: | Thandi Mqoco, André Stander, Anna-Mart Engelbrecht, Anna M Joubert |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2019/1850462 |
Similar Items
-
Quercetin synergistically potentiates the anti-metastatic effect of 5-fluorouracil on the MDA-MB-231 breast cancer cell line
by: Mohammadreza Roshanazadeh, et al.
Published: (2021-07-01) -
Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro.
by: Nadiah Abu, et al.
Published: (2014-01-01) -
Identification of cellular targets for inhibiting MDA-MB-231 migration and invasion
by: Ming-Xian Yang, et al.
Published: (2019) -
Berberine Inhibits MDA-MB-231 Cells by Attenuating Their Inflammatory Responses
by: Lina Zhao, et al.
Published: (2020-01-01) -
Effects of osteopontin inhibition on radiosensitivityof MDA-MB-231 breast cancer cells
by: Hahnel Antje, et al.
Published: (2010-09-01)